BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borgström A, Peinelt C, Stokłosa P. TRPM4 in Cancer-A New Potential Drug Target. Biomolecules 2021;11:229. [PMID: 33562811 DOI: 10.3390/biom11020229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Morelli MB, Nabissi M, Amantini C, Maggi F, Ricci-Vitiani L, Pallini R, Santoni G. TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. Int J Mol Sci 2022;23. [PMID: 36499683 DOI: 10.3390/ijms232315356] [Reference Citation Analysis]
2 Lei J, Deng F, Ding H, Fu M, Xu T, Ji B, Feng L, Li M, Qiu J, Gao Q. Recent Developments on the Roles of Calcium Signals and Potential Therapy Targets in Cervical Cancer. Cells 2022;11:3003. [DOI: 10.3390/cells11193003] [Reference Citation Analysis]
3 Wang J, Qiao S, Liang S, Qian C, Dong Y, Pei M, Wang H, Wan G. TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM. Front Mol Biosci 2022;9:985434. [DOI: 10.3389/fmolb.2022.985434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jeong SA, Yang C, Song J, Song G, Jeong W, Lim W. Hesperidin Suppresses the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress and Disrupting Ca2+ Homeostasis. Antioxidants 2022;11:1633. [DOI: 10.3390/antiox11091633] [Reference Citation Analysis]
5 Wang Z, Dong J, Tian W, Qiao S, Wang H. Role of TRPV1 ion channel in cervical squamous cell carcinoma genesis. Front Mol Biosci 2022;9:980262. [DOI: 10.3389/fmolb.2022.980262] [Reference Citation Analysis]
6 Malysz J, Maxwell SE, Petkov GV. Differential effects of TRPM4 channel inhibitors on Guinea pig urinary bladder smooth muscle excitability and contractility: Novel 4-chloro-2-[2-(2-chloro-phenoxy)-acetylamino]-benzoic acid (CBA) versus classical 9-phenanthrol. Pharmacol Res Perspect 2022;10:e00982. [PMID: 35822549 DOI: 10.1002/prp2.982] [Reference Citation Analysis]
7 Wu Y, Zhang J, Hou C, Wang H, Zhu M, Yao X. A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors. J Oncol 2022;2022:6725570. [PMID: 35747124 DOI: 10.1155/2022/6725570] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Amantini C, Maggi F, Rossi de Vermandois JA, Gubbiotti M, Giannantoni A, Mearini E, Nabissi M, Tomassoni D, Santoni G, Morelli MB. The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer. Cancers 2022;14:3118. [DOI: 10.3390/cancers14133118] [Reference Citation Analysis]
9 Stokłosa P, Kappel S, Peinelt C. A Novel Role of the TRPM4 Ion Channel in Exocytosis. Cells 2022;11:1793. [PMID: 35681487 DOI: 10.3390/cells11111793] [Reference Citation Analysis]
10 Morelli MB, Amantini C. Transient Receptor Potential (TRP) Channels: Markers and Therapeutic Targets for Cancer? Biomolecules 2022;12:547. [DOI: 10.3390/biom12040547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kappel S, Ross-kaschitza D, Hauert B, Rother K, Peinelt C. Title: p53 alters intracellular Ca2+ signaling through regulation of TRPM4. Cell Calcium 2022. [DOI: 10.1016/j.ceca.2022.102591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dienes C, Kovács ZM, Hézső T, Almássy J, Magyar J, Bányász T, Nánási PP, Horváth B, Szentandrássy N. Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease. Pharmaceuticals (Basel) 2021;15:40. [PMID: 35056097 DOI: 10.3390/ph15010040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Stokłosa P, Borgström A, Hauert B, Baur R, Peinelt C. Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer Cells. Cancers (Basel) 2021;13:5400. [PMID: 34771564 DOI: 10.3390/cancers13215400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Berditchevski F, Fennell E, Murray PG. Calcium-dependent signalling in B-cell lymphomas. Oncogene 2021;40:6321-8. [PMID: 34625709 DOI: 10.1038/s41388-021-02025-8] [Reference Citation Analysis]
15 Verigos J, Kordias D, Papadaki S, Magklara A. Transcriptional Profiling of Tumorspheres Reveals TRPM4 as a Novel Stemness Regulator in Breast Cancer. Biomedicines 2021;9:1368. [PMID: 34680485 DOI: 10.3390/biomedicines9101368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Saldías MP, Maureira D, Orellana-Serradell O, Silva I, Lavanderos B, Cruz P, Torres C, Cáceres M, Cerda O. TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer. Front Oncol 2021;11:621614. [PMID: 34178620 DOI: 10.3389/fonc.2021.621614] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
17 Maggi F, Morelli MB, Nabissi M, Marinelli O, Zeppa L, Aguzzi C, Santoni G, Amantini C. Transient Receptor Potential (TRP) Channels in Haematological Malignancies: An Update. Biomolecules 2021;11:765. [PMID: 34065398 DOI: 10.3390/biom11050765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]